View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| HHS/CMS | RIN: 0938-AP52 | Publication ID: Fall 2008 |
| Title: ●Medicare Advantage and Prescription Drug Programs: MIPPA-Related Marketing Revisions (CMS-4138-F) | |
| Abstract: This final rule revises the regulations governing the Medicare Advantage program (Part C), prescription drug benefit program (Part D), and Section 1876 cost plans. | |
| Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
| RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
| Major: No | Unfunded Mandates: No |
| CFR Citation: 42 CFR 417 42 CFR 422 and 423 | |
| Legal Authority: 42 USC 1395w-28(f) | |
Legal Deadline:
|
||||||||||||
Timetable:
|
| Regulatory Flexibility Analysis Required: No | Government Levels Affected: Federal |
| Federalism: No | |
| Included in the Regulatory Plan: No | |
| RIN Data Printed in the FR: No | |
|
Agency Contact: Jerry Mulcahy Division Director of Policy Anaylsis and Planning Group Department of Health and Human Services Centers for Medicare & Medicaid Services Center for Drug and Healthplan Choice, Mailstop C4-23-07, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-1142 Email: jerry.mulcahy@cms.hhs.gov |
|
An official website of the United States government



